Position in RDNT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$19,110,914
-$19,978,183 QoQ
Shares Held
341,938
-37.6% QoQ
Ownership
0.435%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in RDNT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026FRED ALGER MANAGEMENT, LLC holds $517,297,913 across 13 Diagnostics & Research names. RDNT ranks #4 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
1,756,472 | $351,276,835 | |
| 2 | GH |
Guardant Health, Inc.
|
622,259 | $57,478,063 | |
| 3 | ADPT |
Adaptive Biotechnologies Corp
|
2,063,146 | $28,636,466 | |
| 4 | RDNT |
RadNet, Inc.
This page
|
341,938 | $19,110,914 | |
| 5 | VCYT |
Veracyte, Inc.
|
579,460 | $18,664,406 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
24,268 | $13,635,946 | |
| 7 | WGS |
GeneDx Holdings Corp.
|
202,771 | $13,021,953 | |
| 8 | NEO |
Neogenomics Inc
|
651,649 | $4,835,235 |
All Filings in RDNT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,110,914 | 341,938 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $39,089,097 | 547,850 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $37,363,247 | 490,267 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $18,519,935 | 325,425 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,661,516 | 113,868 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $1,781,129 | 25,503 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||